News

Filter

Current filters:

Eli Lilly

101 to 110 of 356 results

India’s patents moves could see particular uncertainty for diabetes sector

India’s patents moves could see particular uncertainty for diabetes sector

17-02-2014

The Indian government's decision to review patented drugs by multinationals, to allow for the manufacture…

Abbott LaboratoriesAsia-PacificDiabetesEli LillyIndiaMarkets & MarketingMerck & CoNovo NordiskPatentsPharmaceutical

Systemic psoriasis market forecast to reach $10.4 billion by 2020

05-02-2014

The systemic psoriasis treatment market value in the eight major countries (8MM) - the USA, Canada, France,…

AmgenapremilastBiotechnologybrodalumabCelgeneDermatologicalsEli LillyMarkets & MarketingNovartisPfizersecukinumabXeljanz

Sanofi sues Eli Lilly over Lantus patent infringement

Sanofi sues Eli Lilly over Lantus patent infringement

31-01-2014

French drug major Sanofi says it has filed a patent infringement suit against USA pharma firm Eli Lilly…

BiosimilarsDiabetesEli LillyLantusLegalNorth AmericaPatentsPharmaceuticalSanofiUSA

Eli Lilly sales beat forecasts, despite 2% decline

Eli Lilly sales beat forecasts, despite 2% decline

30-01-2014

US pharma major Eli Lilly has reported financial results, showing that global sales in the fourth quarter…

Eli LillyFinancialPharmaceutical

Lilly buys back CGRP antibody for migraine prevention from Arteaus Therapeutics

Lilly buys back CGRP antibody for migraine prevention from Arteaus Therapeutics

13-01-2014

Based on positive Phase II data, US drug major Eli Lilly has acquired all development rights for a calcitonin…

Arteaus TherapeuticsEli LillyLicensingLY2951742NeurologicalPharmaceutical

101 to 110 of 356 results

Back to top